Wealth Enhancement Advisory Services, LLC Larimar Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 13,629 shares of LRMR stock, worth $58,468. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,629Holding current value
$58,468% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LRMR
# of Institutions
128Shares Held
65.9MCall Options Held
4.83MPut Options Held
83.7K-
Deerfield Management Company, L.P. (Series C) New York, NY21.2MShares$91.1 Million1.41% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$25.9 Million0.38% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.93MShares$21.1 Million7.71% of portfolio
-
Opaleye Management Inc. Boston, MA4.11MShares$17.6 Million2.84% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.66MShares$15.7 Million0.01% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $186M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...